Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial

Critical Care Medicine

Volumn 37, Issue 3, 2009, Pages 803-810

  Payen, Didier ^a   Mateo, Joaquim ^a   Cavaillon, Jean Marc ^b   Fraisse, François ^c   Floriot, Christian ^d   Vicaut, Eric ^e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT PASTEUR   (France)

^c DELAFONTAINE HOSPITAL   (France)

^d P Morel Hospital   (France)

^e HÔPITAL FERNAND WIDAL   (France)

Author keywords

Cytokines; Hemofiltration; Organ failure; Septic shock

Indexed keywords

CYTOKINE;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FRANCE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; SEPSIS RELATED ORGAN FAILURE ASSESSMENT; SEPTIC SHOCK; HEMOFILTRATION; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; TIME;

FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 62849107393     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181962316     Document Type: Article

References (34)

1. Levy MM, Macias WL, Vincent JL, et al: Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005; 33:2194-2201
2. Annane D, Bellissant E, Cavaillon JM, et al: Septic shock cytokine cascade in sepsis. Lancet 2005; 365:63-78
3. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
4. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
5. 2 Collaborative Group. N Engl J Med 1995; 333:1025-1032
6. Ronco C, Bellomo R: Basic mechanisms and definitions for continuous renal replacement therapies. Int J Artif Organs 1996; 19:95-99
7. Bellomo R, Tipping P, Boyce N: Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 1991; 37:M322-M323
8. De Vriese AS, Vanholder RC, Pascual M, et al: Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med 1999; 25: 903-910
9. Grooteman MP, Groeneveld AB: A role for plasma removal during sepsis? Intensive Care Med 2000; 26:493-495
10. Kellum JA, Song M, Venkataraman R: He-moadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32: 801-805
11. Ponikvar R: Blood purification in the intensive care unit. Nephrol Dial Transplant 2003; 18:v63-v67
12. Tetta C, Bellomo R, Inguaggiato P, et al: Endotoxin and cytokine removal in sepsis. Ther Apher 2002; 6:109-115
13. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
14. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the he-modynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28: 3581-3587
15. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
16. Cole L, Bellomo R, Journois D, et al: High-volume haemofiltration in human septic shock. Intensive Care Med 2001; 27:978-986
17. Tetta C, Gianotti L, Cavaillon JM, et al: Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000; 28:1526-1533
18. Berlot G, Di Capua G, Nosella P, et al: Plas-mapheresis in sepsis. Contrib Nephrol 2004; 144:387-394
19. Honore PM, Joannes-Boyau O: High volume hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004; 27:1077-1082
20. Nalesso F: Plasma filtration adsorption dialysis (PFAD): A new technology for blood purification. Int J Artif Organs 2005; 28: 731-738
21. Rogiers P: High-volume hemofiltration in septic shock. Crit Care 2005; 9:329-330.
22. Ronco C, Brendolan A, d'Intini V, et al: Coupled plasma filtration adsorption: Rationale, technical development and early clinical experience. Blood Purif 2003; 21:409-416
23. Yonekawa M, Rogiers P, Nalesso F, et al: Cytokine and endotoxin removal in critically ill patients. High-volume hemofiltration in septic shock; plasma filtration adsorption dialysis (PFAD): A new technology for blood purification; high volume hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Coupled plasma filtration adsorption: Rationale, technical development and early clinical experience. Ther Apher Dial 2005; 9:A37
24. Morgera S, Haase M, Kuss T, et al: Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34:2099-2104
25. DiScipio AW, Burchard KW: Continuous arteriovenous hemofiltration attenuates poly-morphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis. Am J Surg 1997; 173:174-180
26. Morgera S, Rocktaschel J, Haase M, et al: Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med 2003; 29:1989-1995.
27. Hoffmann JN, Hartl WH, Deppisch R, et al: Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48:1563-1570
28. Tetta C, Cavaillon JM, Schulze M, et al: Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 1998; 13:1458-1464
29. Cole L, Bellomo R, Hart G, et al: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30:100-106
30. Dellinger RP, Carlet JM, Masur H, et al: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555.
31. Rogiers P, Zhang H, Pauwels D, et al: Comparison of polyacrylonitrile (AN69) and poly-sulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med 2003; 31:1219-1225
32. Cavaillon JM, Adib-Conquy M, Fitting C, et al: Cytokine cascade in sepsis. Scand J Infect Dis 2003; 35:535-544
33. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21:522-526
34. Ghani RA, Zainudin S, Ctkong N, et al: Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 2006; 11:386-393